MediPharm Labs Corp.

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: CA58504D1006
CAD
0.07
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.32 k

Shareholding (Mar 2026)

FII

0.00%

Held by 1 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Risky -

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -6.67%, its profits have fallen by -18.6%
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

CAD 32 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

-29.63%

stock-summary
Price to Book

0.91

Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Mar 2026)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.69%
0%
7.69%
6 Months
-6.67%
0%
-6.67%
1 Year
-6.67%
0%
-6.67%
2 Years
0%
0%
0.0%
3 Years
7.69%
0%
7.69%
4 Years
0%
0%
0.0%
5 Years
-85.42%
0%
-85.42%

MediPharm Labs Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.31%
EBIT Growth (5y)
13.17%
EBIT to Interest (avg)
-20.53
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.97
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.91
EV to EBIT
-2.50
EV to EBITDA
-3.06
EV to Capital Employed
0.87
EV to Sales
0.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-34.93%
ROE (Latest)
-29.63%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -18.92% vs -2.63% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 55.00% vs 4.76% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.00",
          "val2": "11.10",
          "chgp": "-18.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-1.50",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.40",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-2.00",
          "chgp": "55.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-94.60%",
          "val2": "-168.40%",
          "chgp": "7.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.38% vs 26.89% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.43% vs 18.32% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.10",
          "val2": "42.00",
          "chgp": "7.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.00",
          "val2": "-9.10",
          "chgp": "23.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.60",
          "chgp": "-83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.70",
          "val2": "1.10",
          "chgp": "54.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.30",
          "val2": "-10.70",
          "chgp": "22.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-191.50%",
          "val2": "-278.90%",
          "chgp": "8.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
9.00
11.10
-18.92%
Operating Profit (PBDIT) excl Other Income
-0.50
-1.50
66.67%
Interest
0.00
0.00
Exceptional Items
0.30
0.40
-25.00%
Consolidate Net Profit
-0.90
-2.00
55.00%
Operating Profit Margin (Excl OI)
-94.60%
-168.40%
7.38%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -18.92% vs -2.63% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 55.00% vs 4.76% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
45.10
42.00
7.38%
Operating Profit (PBDIT) excl Other Income
-7.00
-9.10
23.08%
Interest
0.10
0.60
-83.33%
Exceptional Items
1.70
1.10
54.55%
Consolidate Net Profit
-8.30
-10.70
22.43%
Operating Profit Margin (Excl OI)
-191.50%
-278.90%
8.74%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 7.38% vs 26.89% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 22.43% vs 18.32% in Dec 2024

stock-summaryCompany CV
About MediPharm Labs Corp. stock-summary
stock-summary
MediPharm Labs Corp.
Other Agricultural Products
Medipharm Labs Corp, formerly known as POCML 4 Inc, is a Canada-based medicinal cannabis company specializing in the pharmaceutical grade production of cannabis. The Company is focused on distillation and cannabinoid isolation and purification. The Company actively builds an inventory of specialized consumer products in anticipation of federal legalization of the adult-use market in Canada. Outside of the Canadian market, the Company develops MediPharm Labs Australia facility, which is a purpose-built and component of the Company’s international investments. The Company operates with a processing capacity of approximately 100,000 kilograms of dry cannabis flower and trim per year.
Company Coordinates stock-summary
Company Details
151 John St , BARRIE ON : L4N 2L1
Registrar Details